China Universal Asset Management Co., Ltd. Sage Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,742 shares of SAGE stock, worth $67,281. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,742

Previous 7,070 66.08%

Holding current value

$67,281

Previous $76,000 10.53%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$7.02 - $13.08 $32,797 - $61,109	4,672 Added 66.08%	11,742 $84,000
Q2 2024 Jul 19, 2024	SELL	$10.58 - $17.9 $47,440 - $80,263	-4,484 Reduced 38.81%	7,070 $76,000
Q1 2024 Apr 29, 2024	BUY	$18.62 - $26.95 $85,968 - $124,428	4,617 Added 66.56%	11,554 $217,000
Q4 2023 May 21, 2024	SELL	$17.1 - $22.26 $78,950 - $102,774	-4,617 Reduced 39.96%	6,937 $150,000
Q4 2023 Jan 23, 2024	BUY	$17.1 - $22.26 $92,442 - $120,337	5,406 Added 353.1%	6,937 $150,000
Q3 2023 May 21, 2024	BUY	$16.75 - $48.98 $12,529 - $36,637	748 Added 95.53%	1,531 $31,000
Q3 2023 Oct 30, 2023	BUY	$16.75 - $48.98 $12,529 - $36,637	748 Added 95.53%	1,531 $32,000
Q2 2023 May 21, 2024	SELL	$40.65 - $59.54 $1,056 - $1,548	-26 Reduced 3.21%	783 $36,000
Q2 2023 Jul 27, 2023	SELL	$40.65 - $59.54 $1,056 - $1,548	-26 Reduced 3.21%	783 $37,000
Q1 2023 May 21, 2024	BUY	$37.27 - $46.57 $7,603 - $9,500	204 Added 33.72%	809 $33,000
Q1 2023 Apr 27, 2023	BUY	$37.27 - $46.57 $7,603 - $9,500	204 Added 33.72%	809 $34,000
Q4 2022 May 21, 2024	SELL	$32.2 - $43.61 $352,557 - $477,485	-10,949 Reduced 94.76%	605 $23,000
Q4 2022 Jan 31, 2023	BUY	$32.2 - $43.61 $1,577 - $2,136	49 Added 8.81%	605 $23,000
Q3 2022 Oct 21, 2022	BUY	$32.28 - $43.27 $17,947 - $24,058	556 New	556 $22,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Sage Therapeutics, Inc. Transaction History